Cipla Limited
News and overview for Cipla Limited
Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to Rifaximin [Press Release]
Business Wire | 20 days 17 hours 36 minutes ago
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,612,199 (the ‘199 patent) entitled “Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin”. The patent issued November 3, 2009 and provides protection until June 2024. The ‘199 patent provides further protection relating to composition of matter relating to physical chemical states of rifaximin. Salix has an exclusive license from Alfa Wassermann, S.p.A., to use, se...
H1N1 toll in city reaches seven
Times of India, The | 44 days 15 hours 36 minutes ago
NAGPUR: Dheeraj Goze, a 25-year-old H1N1 man from Jagnath Budhwari who was on ventilator in the swine flu isolation ward at Government Medical College and Hospital (GMCH) since last Sunday, died on Friday at 3 pm.
Research and Markets: Partnering in the Global Generics Industry 2009: a Guide to Companies - Now Available [Press Release]
Business Wire | 40 days 20 hours 55 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/3e7026/partnering_in_the) has announced the addition of the "Partnering in the Global Generics Industry 2009: A Guide to Companies" report to their offering.
New market research report on global generic industry landscape
News-Medical.Net | 40 days 19 hours 23 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/3e7026/partnering_in_the) has announced the addition of the "Partnering in the Global Generics Industry 2009: A Guide to Companies" report to their offering.
4 Results
Sign up for BIO SmartBrief
Company Overview
| Company: | Cipla Limited |
|---|---|
| Industry: | Pharmaceuticals Manufacturers |
| Website: | http://www.cipla.com |
Cipla is a market-leading medicine maker in India. The company has roughly 5,500 pharmaceutical products. Some are sold domestically, while the rest reach international markets in some 170 countries. It offers prescription drugs for all kinds of ailments -- arthritis, cancer, depression -- as well as over-the-counter drugs for colds, oral hygiene, and skin care. Cipla leads the domestic retail pharmaceutical market. The firm also makes bulk drugs, agrochemicals, and animal products. It has eight manufacturing plants located throughout the country. Cipla was founded as The Chemical, Industrial, & Pharmaceutical Laboratories by Khwaja Abdul Hamied in 1935; the founder's sons now head the company.
Key Numbers
| Sales in U.S. Dollars (mil.) | 1,003.5 (2008) |
|---|---|
| One-year % Growth in Sales | 0.0 (2008) |
| Net Income in U.S. Dollars (mil.) | 0 () |
| One-year % Growth in Net Income | 0.0 () |
| Number of Employees | 8,500 (2008) |
| One-year % Growth in Number of Employees | 0.0 (2008) |
| Fiscal Year-End | March |